

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 8.85897250 |
| 2 | exogenous drug catabolic process (GO:0042738) | 8.78892964 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 8.76831619 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.66510132 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.66510132 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.31688833 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.31688833 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.85308799 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.26323477 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.26323477 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.26323477 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.19708434 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.10642874 |
| 14 | drug metabolic process (GO:0017144) | 5.92912950 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.88772252 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.88752631 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.79518810 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.69168875 |
| 19 | urea cycle (GO:0000050) | 5.55009828 |
| 20 | urea metabolic process (GO:0019627) | 5.55009828 |
| 21 | oxidative demethylation (GO:0070989) | 5.49288642 |
| 22 | regulation of plasminogen activation (GO:0010755) | 5.41844543 |
| 23 | cysteine metabolic process (GO:0006534) | 5.40386489 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 5.39399437 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.35575347 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 5.35515903 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.34541259 |
| 28 | regulation of humoral immune response (GO:0002920) | 5.32383628 |
| 29 | protein carboxylation (GO:0018214) | 5.29058433 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.29058433 |
| 31 | regulation of fibrinolysis (GO:0051917) | 5.26447848 |
| 32 | complement activation, alternative pathway (GO:0006957) | 5.24181034 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.21139841 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 5.10230542 |
| 35 | bile acid metabolic process (GO:0008206) | 5.04767364 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.98559111 |
| 37 | regulation of complement activation (GO:0030449) | 4.98410244 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.97779562 |
| 39 | acute-phase response (GO:0006953) | 4.90741899 |
| 40 | ethanol metabolic process (GO:0006067) | 4.85977552 |
| 41 | negative regulation of protein activation cascade (GO:2000258) | 4.85316647 |
| 42 | homocysteine metabolic process (GO:0050667) | 4.80688421 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.76712736 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.74915584 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 4.69915131 |
| 46 | lysine metabolic process (GO:0006553) | 4.67056405 |
| 47 | lysine catabolic process (GO:0006554) | 4.67056405 |
| 48 | reverse cholesterol transport (GO:0043691) | 4.66574506 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 4.65018127 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.60828279 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.60828279 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.58910233 |
| 53 | protein-lipid complex remodeling (GO:0034368) | 4.58910233 |
| 54 | macromolecular complex remodeling (GO:0034367) | 4.58910233 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.58592649 |
| 56 | negative regulation of sterol transport (GO:0032372) | 4.58592649 |
| 57 | imidazole-containing compound metabolic process (GO:0052803) | 4.58170704 |
| 58 | amino-acid betaine metabolic process (GO:0006577) | 4.57301960 |
| 59 | coenzyme catabolic process (GO:0009109) | 4.50243652 |
| 60 | glycine metabolic process (GO:0006544) | 4.44298080 |
| 61 | phospholipid efflux (GO:0033700) | 4.42649846 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 4.42055478 |
| 63 | cellular ketone body metabolic process (GO:0046950) | 4.40388329 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.39679447 |
| 65 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.38770375 |
| 66 | glutamate metabolic process (GO:0006536) | 4.37666751 |
| 67 | amine catabolic process (GO:0009310) | 4.33686200 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 4.33686200 |
| 69 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.32869620 |
| 70 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.32869620 |
| 71 | cellular amino acid catabolic process (GO:0009063) | 4.32370786 |
| 72 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.29243348 |
| 73 | negative regulation of blood coagulation (GO:0030195) | 4.26958670 |
| 74 | negative regulation of hemostasis (GO:1900047) | 4.26958670 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 4.24115993 |
| 76 | plasma lipoprotein particle clearance (GO:0034381) | 4.22743748 |
| 77 | cellular glucuronidation (GO:0052695) | 4.21354130 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 4.18865207 |
| 79 | ethanol oxidation (GO:0006069) | 4.15862358 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 4.15135812 |
| 81 | phenylpropanoid metabolic process (GO:0009698) | 4.15010752 |
| 82 | S-adenosylmethionine metabolic process (GO:0046500) | 4.13034358 |
| 83 | cholesterol efflux (GO:0033344) | 4.10534767 |
| 84 | drug catabolic process (GO:0042737) | 4.08637792 |
| 85 | serine family amino acid biosynthetic process (GO:0009070) | 4.05908629 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.01217387 |
| 87 | flavonoid metabolic process (GO:0009812) | 3.98365148 |
| 88 | negative regulation of wound healing (GO:0061045) | 3.95417463 |
| 89 | arginine metabolic process (GO:0006525) | 3.94449096 |
| 90 | fibrinolysis (GO:0042730) | 3.91258252 |
| 91 | aldehyde catabolic process (GO:0046185) | 3.91222684 |
| 92 | regulation of cholesterol homeostasis (GO:2000188) | 3.91184041 |
| 93 | negative regulation of coagulation (GO:0050819) | 3.88914304 |
| 94 | regulation of bile acid biosynthetic process (GO:0070857) | 3.88519544 |
| 95 | plasma lipoprotein particle assembly (GO:0034377) | 3.87727206 |
| 96 | alkaloid metabolic process (GO:0009820) | 3.86664746 |
| 97 | negative regulation of complement activation (GO:0045916) | 3.83607219 |
| 98 | low-density lipoprotein particle remodeling (GO:0034374) | 3.82663924 |
| 99 | ketone body metabolic process (GO:1902224) | 3.81111562 |
| 100 | acetyl-CoA metabolic process (GO:0006084) | 3.80150806 |
| 101 | cofactor catabolic process (GO:0051187) | 3.77957989 |
| 102 | organic acid catabolic process (GO:0016054) | 3.77002545 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.77002545 |
| 104 | opsonization (GO:0008228) | 3.76980521 |
| 105 | complement activation, classical pathway (GO:0006958) | 3.76055679 |
| 106 | regulation of acute inflammatory response (GO:0002673) | 3.75547661 |
| 107 | glucuronate metabolic process (GO:0019585) | 3.73250940 |
| 108 | uronic acid metabolic process (GO:0006063) | 3.73250940 |
| 109 | blood coagulation, intrinsic pathway (GO:0007597) | 3.72791309 |
| 110 | short-chain fatty acid metabolic process (GO:0046459) | 3.72133576 |
| 111 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.70373698 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.70019975 |
| 113 | complement activation (GO:0006956) | 3.69538330 |
| 114 | acute inflammatory response (GO:0002526) | 3.69530213 |
| 115 | phospholipid homeostasis (GO:0055091) | 3.69106260 |
| 116 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.68243510 |
| 117 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.68243510 |
| 118 | positive regulation of lipid catabolic process (GO:0050996) | 3.66969262 |
| 119 | protein activation cascade (GO:0072376) | 3.66364962 |
| 120 | sterol homeostasis (GO:0055092) | 3.64118521 |
| 121 | negative regulation of lipase activity (GO:0060192) | 3.63139321 |
| 122 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.61806818 |
| 123 | cytolysis (GO:0019835) | 3.57235355 |
| 124 | NAD biosynthetic process (GO:0009435) | 3.56493131 |
| 125 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.54494600 |
| 126 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.54494600 |
| 127 | intestinal cholesterol absorption (GO:0030299) | 3.50573278 |
| 128 | positive regulation of blood coagulation (GO:0030194) | 3.37902409 |
| 129 | positive regulation of hemostasis (GO:1900048) | 3.37902409 |
| 130 | regulation of apoptotic cell clearance (GO:2000425) | 3.36175893 |
| 131 | plasma lipoprotein particle organization (GO:0071827) | 3.35532604 |
| 132 | response to mercury ion (GO:0046689) | 3.32191489 |
| 133 | regulation of triglyceride metabolic process (GO:0090207) | 3.28117562 |
| 134 | response to phenylpropanoid (GO:0080184) | 3.24888727 |
| 135 | arginine catabolic process (GO:0006527) | 3.17650373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.40961248 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.23055493 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.86930853 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.49986118 |
| 5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.19919318 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.01521991 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.96106556 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05095845 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.97377698 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.85900169 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08280916 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03899373 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00233372 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9641001 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.65621192 |
| 16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60129887 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.52578993 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.49321678 |
| 19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42896759 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40744329 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37376650 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30086377 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24820842 |
| 24 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.22841596 |
| 25 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21518117 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18313556 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16520318 |
| 28 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.13429507 |
| 29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10203528 |
| 30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05979588 |
| 31 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03294111 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.00482966 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00008896 |
| 34 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98031951 |
| 35 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97290153 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97133346 |
| 37 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.92009243 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90973422 |
| 39 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90926565 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90877846 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88922653 |
| 42 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86760226 |
| 43 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.86579870 |
| 44 | SA1_27219007_Chip-Seq_Bcells_Human | 0.85755932 |
| 45 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85719533 |
| 46 | * P68_20966046_ChIP-Seq_HELA_Human | 0.85502400 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85034750 |
| 48 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84896447 |
| 49 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83732137 |
| 50 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83717443 |
| 51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83213948 |
| 52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82826062 |
| 53 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81788106 |
| 54 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.81197379 |
| 55 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80098559 |
| 56 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.79331287 |
| 57 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.78954525 |
| 58 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77585838 |
| 59 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77476068 |
| 60 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.77146655 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76255220 |
| 62 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.75193141 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74411743 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73988691 |
| 65 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.73757018 |
| 66 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.73508961 |
| 67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71572765 |
| 68 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.71031703 |
| 69 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.70856148 |
| 70 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.70647574 |
| 71 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.70518680 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.70350385 |
| 73 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.69899731 |
| 74 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.69369272 |
| 75 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69305040 |
| 76 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.69283495 |
| 77 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.69051489 |
| 78 | NFYA_21822215_ChIP-Seq_K562_Human | 0.68674792 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.67367588 |
| 80 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.67193296 |
| 81 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.67108430 |
| 82 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.67074176 |
| 83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66343404 |
| 84 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.66338346 |
| 85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.66013228 |
| 86 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.65963305 |
| 87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65218554 |
| 88 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.64687905 |
| 89 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.64284945 |
| 90 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64076377 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63952977 |
| 92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.63611744 |
| 93 | ERA_21632823_ChIP-Seq_H3396_Human | 0.62482880 |
| 94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62077641 |
| 95 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.61310649 |
| 96 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.61085711 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.60596098 |
| 98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.59505968 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.59505968 |
| 100 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.58896790 |
| 101 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58573996 |
| 102 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.54894993 |
| 103 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54111353 |
| 104 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.53428730 |
| 105 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51094037 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.51052087 |
| 107 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50464629 |
| 108 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49958207 |
| 109 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49849343 |
| 110 | AR_20517297_ChIP-Seq_VCAP_Human | 0.49546083 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.49341982 |
| 112 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.48899866 |
| 113 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47739588 |
| 114 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47683524 |
| 115 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47523025 |
| 116 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46181531 |
| 117 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45895781 |
| 118 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45757097 |
| 119 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.45462849 |
| 120 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45251395 |
| 121 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.44598306 |
| 122 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.44303747 |
| 123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44157314 |
| 124 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43991386 |
| 125 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.43653172 |
| 126 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41006603 |
| 127 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40845945 |
| 128 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40277379 |
| 129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.40037986 |
| 130 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.39600269 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38423206 |
| 132 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.37839649 |
| 133 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.37225124 |
| 134 | GATA2_19941826_ChIP-Seq_K562_Human | 0.36595610 |
| 135 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.36132968 |
| 136 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35074350 |
| 137 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.34926548 |
| 138 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34721841 |
| 139 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34504675 |
| 140 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34441213 |
| 141 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.34336250 |
| 142 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.34125484 |
| 143 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.34069304 |
| 144 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.33955007 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.31265823 |
| 2 | MP0005360_urolithiasis | 7.46705391 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.43166164 |
| 4 | MP0005365_abnormal_bile_salt | 6.10683425 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.15807366 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.24760662 |
| 7 | MP0003252_abnormal_bile_duct | 3.97393851 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.59619531 |
| 9 | MP0009840_abnormal_foam_cell | 3.24812708 |
| 10 | MP0005083_abnormal_biliary_tract | 3.04593490 |
| 11 | MP0003195_calcinosis | 2.93512105 |
| 12 | MP0005332_abnormal_amino_acid | 2.83266373 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.60211434 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.31351936 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.19955578 |
| 16 | MP0000609_abnormal_liver_physiology | 2.18729704 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.14201871 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.93313596 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.83462062 |
| 20 | MP0003868_abnormal_feces_composition | 1.80247089 |
| 21 | MP0001764_abnormal_homeostasis | 1.60563782 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56272912 |
| 23 | MP0005451_abnormal_body_composition | 1.54343884 |
| 24 | MP0009697_abnormal_copulation | 1.43748625 |
| 25 | MP0003011_delayed_dark_adaptation | 1.28732748 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.28587819 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.23060615 |
| 28 | MP0003186_abnormal_redox_activity | 1.22516831 |
| 29 | MP0002254_reproductive_system_inflammat | 1.22158147 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.19212066 |
| 31 | MP0000598_abnormal_liver_morphology | 1.17915100 |
| 32 | MP0005647_abnormal_sex_gland | 1.15719181 |
| 33 | MP0002249_abnormal_larynx_morphology | 1.11711817 |
| 34 | MP0003879_abnormal_hair_cell | 1.11458660 |
| 35 | MP0000566_synostosis | 1.08927022 |
| 36 | MP0000604_amyloidosis | 1.08153564 |
| 37 | MP0002332_abnormal_exercise_endurance | 1.04631157 |
| 38 | MP0009764_decreased_sensitivity_to | 1.03221252 |
| 39 | MP0002282_abnormal_trachea_morphology | 1.00972198 |
| 40 | MP0009763_increased_sensitivity_to | 0.99554674 |
| 41 | MP0010368_abnormal_lymphatic_system | 0.98358222 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 0.96934793 |
| 43 | MP0005670_abnormal_white_adipose | 0.90818176 |
| 44 | MP0002132_abnormal_respiratory_system | 0.90398314 |
| 45 | MP0009642_abnormal_blood_homeostasis | 0.87437190 |
| 46 | MP0008469_abnormal_protein_level | 0.86241281 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 0.83205719 |
| 48 | MP0002971_abnormal_brown_adipose | 0.81757238 |
| 49 | MP0005408_hypopigmentation | 0.80153745 |
| 50 | MP0000467_abnormal_esophagus_morphology | 0.80089587 |
| 51 | MP0002876_abnormal_thyroid_physiology | 0.78444647 |
| 52 | MP0005376_homeostasis/metabolism_phenot | 0.78355227 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 0.78223643 |
| 54 | MP0005084_abnormal_gallbladder_morpholo | 0.77233791 |
| 55 | MP0009765_abnormal_xenobiotic_induced | 0.74051388 |
| 56 | MP0004084_abnormal_cardiac_muscle | 0.74006832 |
| 57 | MP0005220_abnormal_exocrine_pancreas | 0.73178605 |
| 58 | MP0005334_abnormal_fat_pad | 0.73123245 |
| 59 | MP0001661_extended_life_span | 0.72740911 |
| 60 | MP0004130_abnormal_muscle_cell | 0.72176351 |
| 61 | MP0005330_cardiomyopathy | 0.71413543 |
| 62 | MP0006138_congestive_heart_failure | 0.68633644 |
| 63 | MP0005535_abnormal_body_temperature | 0.68271333 |
| 64 | MP0003690_abnormal_glial_cell | 0.66047881 |
| 65 | MP0008775_abnormal_heart_ventricle | 0.66008634 |
| 66 | MP0005266_abnormal_metabolism | 0.65262247 |
| 67 | MP0001756_abnormal_urination | 0.65126022 |
| 68 | MP0003329_amyloid_beta_deposits | 0.64645609 |
| 69 | MP0009053_abnormal_anal_canal | 0.61370473 |
| 70 | MP0002234_abnormal_pharynx_morphology | 0.60851716 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 0.59326843 |
| 72 | MP0005595_abnormal_vascular_smooth | 0.58911134 |
| 73 | MP0006035_abnormal_mitochondrial_morpho | 0.58410378 |
| 74 | MP0005448_abnormal_energy_balance | 0.57152450 |
| 75 | MP0000639_abnormal_adrenal_gland | 0.55815818 |
| 76 | MP0000678_abnormal_parathyroid_gland | 0.53840653 |
| 77 | MP0005187_abnormal_penis_morphology | 0.52254207 |
| 78 | MP0005023_abnormal_wound_healing | 0.52110992 |
| 79 | MP0005395_other_phenotype | 0.51375784 |
| 80 | MP0002136_abnormal_kidney_physiology | 0.51079920 |
| 81 | MP0001986_abnormal_taste_sensitivity | 0.49909254 |
| 82 | MP0003718_maternal_effect | 0.49795223 |
| 83 | MP0003878_abnormal_ear_physiology | 0.48761552 |
| 84 | MP0005377_hearing/vestibular/ear_phenot | 0.48761552 |
| 85 | MP0003638_abnormal_response/metabolism_ | 0.48013369 |
| 86 | MP0005464_abnormal_platelet_physiology | 0.47754432 |
| 87 | MP0002089_abnormal_postnatal_growth/wei | 0.47573422 |
| 88 | MP0004036_abnormal_muscle_relaxation | 0.47483466 |
| 89 | MP0005409_darkened_coat_color | 0.47383807 |
| 90 | MP0002822_catalepsy | 0.47037765 |
| 91 | MP0003724_increased_susceptibility_to | 0.46366518 |
| 92 | MP0002928_abnormal_bile_duct | 0.46255672 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.45913186 |
| 94 | MP0010630_abnormal_cardiac_muscle | 0.45815000 |
| 95 | MP0001544_abnormal_cardiovascular_syste | 0.45804127 |
| 96 | MP0005385_cardiovascular_system_phenoty | 0.45804127 |
| 97 | MP0008874_decreased_physiological_sensi | 0.44168043 |
| 98 | MP0002837_dystrophic_cardiac_calcinosis | 0.44007290 |
| 99 | MP0003953_abnormal_hormone_level | 0.42554838 |
| 100 | MP0008873_increased_physiological_sensi | 0.42158963 |
| 101 | MP0009384_cardiac_valve_regurgitation | 0.41226287 |
| 102 | MP0003436_decreased_susceptibility_to | 0.40084592 |
| 103 | MP0005166_decreased_susceptibility_to | 0.40060022 |
| 104 | MP0009785_altered_susceptibility_to | 0.39665680 |
| 105 | MP0004215_abnormal_myocardial_fiber | 0.39494401 |
| 106 | MP0005375_adipose_tissue_phenotype | 0.38696956 |
| 107 | MP0003075_altered_response_to | 0.38502676 |
| 108 | MP0000579_abnormal_nail_morphology | 0.38474355 |
| 109 | MP0002796_impaired_skin_barrier | 0.38314838 |
| 110 | MP0001915_intracranial_hemorrhage | 0.38178697 |
| 111 | MP0000751_myopathy | 0.37849566 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.37682559 |
| 113 | MP0009672_abnormal_birth_weight | 0.37604049 |
| 114 | MP0005248_abnormal_Harderian_gland | 0.36953354 |
| 115 | MP0002128_abnormal_blood_circulation | 0.36614827 |
| 116 | MP0008872_abnormal_physiological_respon | 0.36227305 |
| 117 | MP0002098_abnormal_vibrissa_morphology | 0.35847450 |
| 118 | MP0009115_abnormal_fat_cell | 0.35593229 |
| 119 | MP0002970_abnormal_white_adipose | 0.34387895 |
| 120 | MP0002168_other_aberrant_phenotype | 0.34353921 |
| 121 | MP0004381_abnormal_hair_follicle | 0.34180266 |
| 122 | MP0000230_abnormal_systemic_arterial | 0.33970099 |
| 123 | MP0006082_CNS_inflammation | 0.33483968 |
| 124 | MP0001881_abnormal_mammary_gland | 0.31493295 |
| 125 | MP0000249_abnormal_blood_vessel | 0.31463309 |
| 126 | MP0001243_abnormal_dermal_layer | 0.30088562 |
| 127 | MP0004883_abnormal_blood_vessel | 0.28912015 |
| 128 | MP0005058_abnormal_lysosome_morphology | 0.28657340 |
| 129 | MP0002060_abnormal_skin_morphology | 0.26773760 |
| 130 | MP0001853_heart_inflammation | 0.26431609 |
| 131 | MP0004264_abnormal_extraembryonic_tissu | 0.26151771 |
| 132 | MP0001845_abnormal_inflammatory_respons | 0.25099840 |
| 133 | MP0010234_abnormal_vibrissa_follicle | 0.25019588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.44148796 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.24921763 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.22726426 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.64632014 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.43028686 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.31365814 |
| 7 | Xanthomatosis (HP:0000991) | 6.22576337 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.57880122 |
| 9 | Complement deficiency (HP:0004431) | 5.25338274 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.71341388 |
| 11 | Joint hemorrhage (HP:0005261) | 4.64681702 |
| 12 | Hyperglycinemia (HP:0002154) | 4.60646810 |
| 13 | Hyperammonemia (HP:0001987) | 4.59975537 |
| 14 | Epidermoid cyst (HP:0200040) | 4.51401469 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.40752306 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.30027260 |
| 17 | Ketosis (HP:0001946) | 4.29911257 |
| 18 | Nephritis (HP:0000123) | 4.26196641 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.23522215 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.20190224 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.17940895 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.17149343 |
| 23 | Hyperglycinuria (HP:0003108) | 4.17112593 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 4.11924552 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.11924552 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.08051629 |
| 27 | Fat malabsorption (HP:0002630) | 4.03553130 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.87694989 |
| 29 | Abnormality of complement system (HP:0005339) | 3.81932375 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.76508397 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.71615315 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.67682935 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.60595267 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.36690436 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.34778973 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.28198106 |
| 37 | Spontaneous abortion (HP:0005268) | 3.25331360 |
| 38 | Myocardial infarction (HP:0001658) | 3.17175646 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.10458983 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.10095492 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.08624174 |
| 42 | Ketoacidosis (HP:0001993) | 3.07585251 |
| 43 | Steatorrhea (HP:0002570) | 3.01420090 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.92954516 |
| 45 | Neonatal hypoglycemia (HP:0001998) | 2.91870721 |
| 46 | Hypochromic microcytic anemia (HP:0004840) | 2.81588627 |
| 47 | Skin nodule (HP:0200036) | 2.80757907 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.79533765 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.77128604 |
| 50 | Metabolic acidosis (HP:0001942) | 2.75624815 |
| 51 | Vascular calcification (HP:0004934) | 2.73068013 |
| 52 | Fair hair (HP:0002286) | 2.65267302 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.63845403 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.63845403 |
| 55 | Gout (HP:0001997) | 2.63624530 |
| 56 | Lethargy (HP:0001254) | 2.60590742 |
| 57 | Mitral stenosis (HP:0001718) | 2.51897977 |
| 58 | Malnutrition (HP:0004395) | 2.50050671 |
| 59 | Spastic diplegia (HP:0001264) | 2.48991804 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.47912592 |
| 61 | Abnormal gallbladder morphology (HP:0012437) | 2.44800892 |
| 62 | Cardiovascular calcification (HP:0011915) | 2.42806414 |
| 63 | Acanthocytosis (HP:0001927) | 2.40839292 |
| 64 | Cholelithiasis (HP:0001081) | 2.39239458 |
| 65 | Irritability (HP:0000737) | 2.37311974 |
| 66 | Glomerulonephritis (HP:0000099) | 2.36042900 |
| 67 | Cerebral edema (HP:0002181) | 2.33432467 |
| 68 | Neonatal onset (HP:0003623) | 2.33049606 |
| 69 | Cholecystitis (HP:0001082) | 2.29026546 |
| 70 | Abnormal gallbladder physiology (HP:0012438) | 2.29026546 |
| 71 | Cerebral palsy (HP:0100021) | 2.28436376 |
| 72 | Amyloidosis (HP:0011034) | 2.27883687 |
| 73 | Osteomalacia (HP:0002749) | 2.24457395 |
| 74 | Gingival bleeding (HP:0000225) | 2.20623005 |
| 75 | Sensorimotor neuropathy (HP:0007141) | 2.19481134 |
| 76 | Esophageal varix (HP:0002040) | 2.18185668 |
| 77 | Atrioventricular block (HP:0001678) | 2.17772089 |
| 78 | Late onset (HP:0003584) | 2.17197084 |
| 79 | Brushfield spots (HP:0001088) | 2.17020619 |
| 80 | Purpura (HP:0000979) | 2.15565785 |
| 81 | Joint swelling (HP:0001386) | 2.13752969 |
| 82 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11791945 |
| 83 | Enlarged kidneys (HP:0000105) | 2.11602862 |
| 84 | Pancreatitis (HP:0001733) | 2.11256416 |
| 85 | Hemorrhage of the eye (HP:0011885) | 2.11224783 |
| 86 | Vomiting (HP:0002013) | 2.09752308 |
| 87 | Thrombophlebitis (HP:0004418) | 2.09020557 |
| 88 | Menorrhagia (HP:0000132) | 2.06273622 |
| 89 | Generalized aminoaciduria (HP:0002909) | 2.05151514 |
| 90 | Abnormality of the Achilles tendon (HP:0005109) | 2.04813414 |
| 91 | Opisthotonus (HP:0002179) | 2.03739563 |
| 92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02352154 |
| 93 | Rickets (HP:0002748) | 2.02304361 |
| 94 | Hydroxyprolinuria (HP:0003080) | 2.01814020 |
| 95 | Abnormality of proline metabolism (HP:0010907) | 2.01814020 |
| 96 | Abnormality of the gallbladder (HP:0005264) | 2.00147746 |
| 97 | Hypophosphatemic rickets (HP:0004912) | 2.00020257 |
| 98 | Generalized hypopigmentation of hair (HP:0011358) | 1.96894563 |
| 99 | Abnormal cartilage morphology (HP:0002763) | 1.96355553 |
| 100 | Arthropathy (HP:0003040) | 1.94858848 |
| 101 | Poikilocytosis (HP:0004447) | 1.94472810 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 1.93952068 |
| 103 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92200819 |
| 104 | Pulmonary embolism (HP:0002204) | 1.91516180 |
| 105 | Alkalosis (HP:0001948) | 1.88553856 |
| 106 | Elevated alkaline phosphatase (HP:0003155) | 1.85775098 |
| 107 | Blue irides (HP:0000635) | 1.84285686 |
| 108 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81218775 |
| 109 | Renal cortical cysts (HP:0000803) | 1.80617638 |
| 110 | Status epilepticus (HP:0002133) | 1.80472500 |
| 111 | Elevated hepatic transaminases (HP:0002910) | 1.79534674 |
| 112 | Hyperuricemia (HP:0002149) | 1.78005462 |
| 113 | Increased purine levels (HP:0004368) | 1.78005462 |
| 114 | Hyperglycemia (HP:0003074) | 1.76773455 |
| 115 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.71242418 |
| 116 | Increased serum ferritin (HP:0003281) | 1.70232597 |
| 117 | Retinal atrophy (HP:0001105) | 1.64314831 |
| 118 | Lymphangioma (HP:0100764) | 1.61547265 |
| 119 | Gangrene (HP:0100758) | 1.61006017 |
| 120 | Epistaxis (HP:0000421) | 1.60682200 |
| 121 | Heart block (HP:0012722) | 1.59219870 |
| 122 | Abnormal delivery (HP:0001787) | 1.56555635 |
| 123 | Focal segmental glomerulosclerosis (HP:0000097) | 1.55658888 |
| 124 | Abnormal atrioventricular conduction (HP:0005150) | 1.55639301 |
| 125 | Increased mean platelet volume (HP:0011877) | 1.52355249 |
| 126 | Facial shape deformation (HP:0011334) | 1.52296054 |
| 127 | Potter facies (HP:0002009) | 1.52296054 |
| 128 | Back pain (HP:0003418) | 1.49722020 |
| 129 | Abnormal platelet function (HP:0011869) | 1.44130814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.94925992 |
| 2 | FGFR4 | 4.84494509 |
| 3 | SIK1 | 4.76231880 |
| 4 | ERN1 | 4.46213193 |
| 5 | NTRK3 | 3.58571818 |
| 6 | TAOK3 | 3.06846319 |
| 7 | ERBB4 | 3.01055455 |
| 8 | INSRR | 2.97432819 |
| 9 | MUSK | 2.56362531 |
| 10 | MYLK | 2.55801818 |
| 11 | MAP2K4 | 2.16159562 |
| 12 | PKN2 | 2.15958296 |
| 13 | MST1R | 2.15025074 |
| 14 | PIK3CA | 2.13785470 |
| 15 | TRIB3 | 1.90843529 |
| 16 | MAPK11 | 1.89161919 |
| 17 | FLT3 | 1.78780770 |
| 18 | MAPKAPK3 | 1.78459430 |
| 19 | PIK3CG | 1.77530017 |
| 20 | TYK2 | 1.76411660 |
| 21 | LATS1 | 1.75647545 |
| 22 | PTK6 | 1.59753480 |
| 23 | NLK | 1.55434776 |
| 24 | DAPK2 | 1.52960534 |
| 25 | EPHA2 | 1.49030915 |
| 26 | FGFR2 | 1.41590880 |
| 27 | ABL2 | 1.40243585 |
| 28 | DMPK | 1.38694710 |
| 29 | MAP3K7 | 1.31454097 |
| 30 | FRK | 1.29459919 |
| 31 | NEK9 | 1.28470140 |
| 32 | KDR | 1.28390201 |
| 33 | JAK2 | 1.24021284 |
| 34 | FER | 1.22629561 |
| 35 | PRKAA2 | 1.21874092 |
| 36 | CDC42BPA | 1.14116688 |
| 37 | MAPK15 | 1.11889374 |
| 38 | PINK1 | 1.10540519 |
| 39 | TNK2 | 1.10282431 |
| 40 | ERBB2 | 1.07889608 |
| 41 | STK38L | 1.02304764 |
| 42 | JAK1 | 1.01937238 |
| 43 | PDK2 | 1.01313929 |
| 44 | MAP3K10 | 1.01213805 |
| 45 | MAP2K3 | 1.00494768 |
| 46 | GRK6 | 0.97418222 |
| 47 | TBK1 | 0.96103604 |
| 48 | MAPK4 | 0.92665085 |
| 49 | MAP3K14 | 0.91117853 |
| 50 | TTN | 0.89574355 |
| 51 | PRKCZ | 0.89377898 |
| 52 | CAMK1D | 0.89160369 |
| 53 | MET | 0.88065776 |
| 54 | RPS6KA2 | 0.86297843 |
| 55 | SMG1 | 0.84653252 |
| 56 | EPHB1 | 0.84412195 |
| 57 | RPS6KL1 | 0.84314105 |
| 58 | RPS6KC1 | 0.84314105 |
| 59 | RPS6KA6 | 0.81785778 |
| 60 | CDK6 | 0.80411813 |
| 61 | PRKD2 | 0.80369662 |
| 62 | MAP3K3 | 0.77518973 |
| 63 | TIE1 | 0.75129213 |
| 64 | MAPK12 | 0.74735610 |
| 65 | DYRK1B | 0.74012741 |
| 66 | SIK2 | 0.73878203 |
| 67 | PRKACG | 0.73847168 |
| 68 | PRKAA1 | 0.73777252 |
| 69 | DAPK3 | 0.73418811 |
| 70 | PRKACA | 0.73212334 |
| 71 | TGFBR2 | 0.72354403 |
| 72 | EEF2K | 0.72165879 |
| 73 | BMPR1B | 0.71572744 |
| 74 | CAMK2G | 0.71260063 |
| 75 | EPHA3 | 0.70196613 |
| 76 | GSK3A | 0.69630655 |
| 77 | MARK2 | 0.68962286 |
| 78 | STK38 | 0.68781800 |
| 79 | SGK3 | 0.67777612 |
| 80 | CSK | 0.67403227 |
| 81 | IRAK3 | 0.66520745 |
| 82 | MAP2K6 | 0.65575220 |
| 83 | EPHB2 | 0.65004520 |
| 84 | TGFBR1 | 0.63532992 |
| 85 | PTK2 | 0.63159900 |
| 86 | MAP3K11 | 0.63154099 |
| 87 | RIPK1 | 0.62131000 |
| 88 | MAP3K2 | 0.61150438 |
| 89 | PRPF4B | 0.59520722 |
| 90 | FGFR3 | 0.58799203 |
| 91 | PDPK1 | 0.56835775 |
| 92 | ACVR1B | 0.55666369 |
| 93 | PRKD1 | 0.54375868 |
| 94 | MAPK7 | 0.50413880 |
| 95 | PRKG1 | 0.50131082 |
| 96 | CSNK1G1 | 0.49651753 |
| 97 | ROCK1 | 0.49173813 |
| 98 | SGK2 | 0.47906524 |
| 99 | MAP3K6 | 0.47098544 |
| 100 | STK11 | 0.46853972 |
| 101 | ICK | 0.46064105 |
| 102 | EPHA4 | 0.46046942 |
| 103 | MAP3K13 | 0.45954919 |
| 104 | MTOR | 0.44333383 |
| 105 | AKT3 | 0.42811559 |
| 106 | IKBKE | 0.42797235 |
| 107 | PDK3 | 0.42127620 |
| 108 | PDK4 | 0.42127620 |
| 109 | PRKCQ | 0.41727988 |
| 110 | CDK4 | 0.41725526 |
| 111 | CAMK1G | 0.41387597 |
| 112 | OBSCN | 0.40557360 |
| 113 | CSF1R | 0.40093797 |
| 114 | MAP2K1 | 0.39916657 |
| 115 | PRKCE | 0.39708268 |
| 116 | RPS6KA3 | 0.39285471 |
| 117 | PDGFRB | 0.38990738 |
| 118 | IGF1R | 0.38940760 |
| 119 | LATS2 | 0.38706503 |
| 120 | TAOK2 | 0.37524745 |
| 121 | RET | 0.36342506 |
| 122 | SGK223 | 0.36092126 |
| 123 | SGK494 | 0.36092126 |
| 124 | PKN1 | 0.35743021 |
| 125 | PRKCG | 0.34179230 |
| 126 | GRK1 | 0.33869576 |
| 127 | PDK1 | 0.31565454 |
| 128 | MAP3K5 | 0.31055833 |
| 129 | MAP3K1 | 0.29315334 |
| 130 | EGFR | 0.29232692 |
| 131 | CAMK4 | 0.28541005 |
| 132 | CSNK1G2 | 0.27312214 |
| 133 | MAP2K2 | 0.25477498 |
| 134 | PRKCA | 0.24500186 |
| 135 | CSNK1G3 | 0.24306357 |
| 136 | PAK3 | 0.24059340 |
| 137 | BMX | 0.23307909 |
| 138 | PDGFRA | 0.22669901 |
| 139 | IRAK2 | 0.22380392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.44489009 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53047037 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33809625 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.28764113 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.02238422 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.73681367 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.72067568 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70804580 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67931477 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55721171 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52522401 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41259645 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27709560 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18944309 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.09629318 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09466309 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.95925541 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95546000 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.91620216 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90927223 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.88845613 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87822299 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84678453 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78198709 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74955795 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73260865 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72460742 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70240739 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70004479 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66655684 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61301962 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58826284 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57024441 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52127927 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.51455143 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44843788 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43301118 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40596510 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32563027 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31702426 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29822273 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26623683 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.23296611 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23157663 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20831497 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17115283 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15454013 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15012488 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10671429 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06581245 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.06297696 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00778125 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97176938 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94117271 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94082571 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91539242 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86799133 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84901345 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.84138006 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79347699 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71682409 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70839464 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66456057 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57706306 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57345312 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53678885 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46513839 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41983756 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.35008483 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.32651233 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30558172 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26694101 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.25460213 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24791063 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24588603 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20693779 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20654167 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.18689690 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17064861 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13095648 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.08444251 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04064955 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.03950475 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.01644099 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | -0.2382126 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2285728 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2273468 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2238755 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2188580 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2041907 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1996383 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | -0.1985454 |
| 93 | Cocaine addiction_Homo sapiens_hsa05030 | -0.1946286 |
| 94 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.1809599 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1800597 |
| 96 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.1790652 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1769800 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1699566 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | -0.1697578 |
| 100 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.1642238 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1570125 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1464057 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1456903 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1295638 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1114854 |
| 106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1078780 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1044070 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0918196 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0850964 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0714419 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0683250 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0469050 |

